Ironwood Pharmaceuticals Affirms FY2026 Sales Guidance of $450.000M-$475.000M vs $458.593M Est
Benzinga Newsdesk 6 months ago
NewsGuidance
Ironwood Pharmaceuticals (NASDAQ:IRWD) affirms FY2026 sales outlook from $450.000 million-$475.000 million to $450.000 million-$475.000 million vs $458.593 million estimate.
Ironwood Pharmaceuticals (NASDAQ:IRWD) affirms FY2026 sales outlook from $450.000 million-$475.000 million to $450.000 million-$475.000 million vs $458.593 million estimate.